390Indexalkaline phosphatase, 74alkenes, 338alkylation, 90, 113allele, 69, 70, 339Allium cepa, 247, 248allopurinol, 30alpha, 16, 33, 43, 69, 119, 150, 156, 166, 173, 182,211, 233, 257, 290, 291, 294, 296, 311, 352alpha-tocopherol, 33, 43, 119, 156, 166, 173, 182,211, 291, 296, 311, 352ALT, 57alternative, 68, 195, 220, 364, 371, 379alternative medicine, 364alters, 344, 345alveolar macrophages, 364American Diabetes Association, 148amines, 88, 91, 219, 283, 291amino acid, ix, 13, 46, 70, 71, 77, 128, 219, 220,239, 251, 258, 284, 304, 379ammonium, 156amphetamine, 306anaemia, 222anaerobic, 5, 11, 15, 17, 18, 20, 21, 27, 28, 29, 32,35, 38, 137analog, 250analysis <strong>of</strong> variance, 55androgen, 230, 377, 382anemia, 136, 238, 251angiogenesis, xvi, 169, 182, 367, 369, 371, 373, 375angiogenic, 371, 375angiography, 345, 347angiotensin converting enzyme (ACE), 16, 17, 37angiotensin II, 17animal models, 169, 309, 312, 345animal studies, xii, 238, 252, 334, 337animal tissues, 79, 83, 190, 229, 236anorexia, 136anthracene, 249anthropogenic, xiv, 313anti-angiogenic, 375antiapoptotic, 92anti-apoptotic, x, 88, 92, 116antibacterial, 6antibody, 13, 186anticancer, 91, 124, 167, 169, 197, 204, 242anticancer activity, 167, 170, 242anticancer drug, 204anticonvulsant, 306, 308, 311antigen, 220antihypertensive agents, 197antihypertensive drugs, 17antineoplastic, 150, 178, 206antioxidant complex, 150antioxidative, 154, 161, 387antisense, 203antisense oligonucleotides, 203antitumor, 119, 181antiviral, 224AOC, 13aortic stenosis, 152APL, 175apoptotic, x, 88, 92, 93, 99, 100, 110, 111, 115, 116,119, 122, 173, 174, 177, 370, 374apoptotic cells, 99, 100, 110, 111, 115, 116apoptotic effect, x, 88, 92, 115, 116apoptotic mechanisms, 370aqueous humor, 235aqueous solution, 194, 208arachidonic acid, 12, 305arginine, 132, 133, 146, 284, 293, 302, 334, 340,344, 345, 350, 351, 352arrest, 119, 169, 292, 370, 374arsenic, 124, 175, 176arsenic trioxide, 176ART, 287arterial hypertension, 337, 344arteries, 133, 147, 148, 224, 257, 339, 352artery, 135, 146, 147, 148, 151, 180, 256, 336, 344,345, 346, 347, 350, 352, 353articular cartilage, 229aryl hydrocarbon receptor, 120ASEAN, 210Asia, 33, 53, 63, 79, 83, 365Asian, 70, 83, 246Asian countries, 70aspartate, 300, 307asphyxia, 35aspirin, 345assessment, 11, 12, 14, 19, 179, 198, 277, 325, 326,363association, 275, 276asthma, 225, 232, 238, 302, 364, 365astrocytes, 218, 225, 229, 231, 234, 303, 310astroglial, 231asymptomatic, 340atherogenesis, xii, 37, 80, 237atherosclerosis, xv, 5, 7, 15, 33, 49, 132, 146, 151,182, 224, 241, 249, 302, 332, 336, 338, 343, 344,345, 346, 349, 352, 353Atherosclerosis Risk in Communities (ARIC), 151
Index 391atherosclerotic plaque, 238, 243atmosphere, 93, 98, 99, 100atoms, 5, 90, 154, 157, 301, 331atopic eczema, 163, 164ATP, 8, 10, 129, 196, 241, 368ATPase, 35, 218, 306, 310, 333atresia, 283atrophy, 378Australia, 355, 357Austria, 144, 153, 211autonomic nerve, 351autooxidation, 157, 159, 166, 167, 179BB lymphocytes, 149B vitamins, 187bacteria, 9, 137, 150bacterial, 71, 74, 137, 180, 206, 229, 379bacterial cells, 180bacterial infection, 137bananas, 266barrier, 159, 228, 230basal lamina, 282basement membrane, 369, 374basketball, 29, 43batteries, 330, 331, 333Bax, 370Bcl-2, 173BDI, 156beef, 366behavior, xiii, 193, 198, 211, 262, 271, 277, 306behaviours, 202beneficial effect, xv, 91, 114, 118, 224, 243, 330,337, 343, 345, 348, 349, 350, 363, 370, 371benefits, viii, xii, xvii, 2, 3, 5, 23, 31, 134, 164, 165,181, 190, 237, 257, 330, 348, 365, 385benign, 183benzo(a)pyrene, 91, 113, 115, 120beta cell, 255beta-carotene, 16, 24, 25, 29, 37, 43, 143, 146, 166,181, 182, 359, 362, 364beverages, 264, 386bias, 19, 264, 363bicarbonate, 245bile, 117, 129, 226, 234, 241bile acids, 129, 226, 234, 241bile duct, 117bilirubin, 6, 13, 226biliverdin reductase, 233bioactive compounds, 121, 387bioavailability, 2, 3, 17, 129, 130, 131, 134, 144,165, 203, 227, 250, 333, 344, 345, 349, 368, 386biochemistry, 33, 54, 63, 68, 146, 254, 256, 309biocompatibility, 198biocompatible, 195, 196biodegradability, 186biodegradable, 196, 203, 204biodiversity, 327bi<strong>of</strong>lavonoids, 6, 13biogenesis, 30, 31, 42, 65, 84, 145biological activity, 48, 187biological macromolecules, 48, 186, 284biological systems, vii, xi, 1, 4, 5, 8, 9, 13, 36, 153,180, 188, 239, 301biomaterials, 196, 197biometals, 340biomolecules, x, 4, 11, 12, 22, 24, 153, 157, 159,171, 301, 308biomonitoring, 315, 324, 327biopsies, 167, 168biosynthesis, vii, xi, xii, 62, 72, 81, 82, 141, 149,185, 215, 231, 233, 237, 239, 282, 290, 309, 372,379, 380, 383biosynthetic pathways, 239biotic, 314biotin, 188biotransformation, 114, 123, 165bipolar, 312birth, xiii, 220, 281, 283, 286, 288, 289, 293, 304birth weight, xiii, 281, 286, 288, 289, 293bismuth, 331bladder, 70, 81, 89, 118, 138, 170, 369, 373bladder cancer, 70, 81, 118blastocyst, 283, 285, 292blocks, 35, 333blood and body fluids, 223blood flow, 135, 149, 238, 250, 295, 333, 334, 340,345, 346, 347, 352blood glucose, 53, 134, 149blood lead levels, 334, 337, 341blood plasma, 123, 176, 230, 254, 303, 304, 309blood pressure, xv, 57, 76, 132, 147, 224, 243, 256,329, 333, 337, 340, 346, 353blood urea nitrogen, 57blood vessels, xii, 128, 132, 169, 237, 238, 340blood-brain barrier, 228, 230bloodstream, 331body fluid, 12, 136, 183, 223, 273body mass, 52, 264, 274, 279, 360
- Page 7 and 8:
ContentsPrefaceChapter IChapter IIC
- Page 9 and 10:
PrefaceThe 6-carbon lactone known a
- Page 11 and 12:
Prefaceixbalance of antioxidant and
- Page 13 and 14:
Prefacexiprovided or is contradicto
- Page 15 and 16:
PrefacexiiiChapter IX - Background:
- Page 17 and 18:
Prefacexvdetoxification defence sys
- Page 19:
Prefacexviiprogressed faster than i
- Page 22 and 23:
2Kelsey H. Fisher-Wellman and Richa
- Page 24 and 25:
4Kelsey H. Fisher-Wellman and Richa
- Page 26 and 27:
6Kelsey H. Fisher-Wellman and Richa
- Page 28 and 29:
8Kelsey H. Fisher-Wellman and Richa
- Page 30 and 31:
10Kelsey H. Fisher-Wellman and Rich
- Page 32 and 33:
12Kelsey H. Fisher-Wellman and Rich
- Page 34 and 35:
14Kelsey H. Fisher-Wellman and Rich
- Page 36 and 37:
16Kelsey H. Fisher-Wellman and Rich
- Page 38 and 39:
18Kelsey H. Fisher-Wellman and Rich
- Page 40 and 41:
20Kelsey H. Fisher-Wellman and Rich
- Page 42 and 43:
22Kelsey H. Fisher-Wellman and Rich
- Page 44 and 45:
24Kelsey H. Fisher-Wellman and Rich
- Page 46 and 47:
26Kelsey H. Fisher-Wellman and Rich
- Page 48 and 49:
28Kelsey H. Fisher-Wellman and Rich
- Page 50 and 51:
30Kelsey H. Fisher-Wellman and Rich
- Page 52 and 53:
32Kelsey H. Fisher-Wellman and Rich
- Page 54 and 55:
34Kelsey H. Fisher-Wellman and Rich
- Page 56 and 57:
36Kelsey H. Fisher-Wellman and Rich
- Page 58 and 59:
38Kelsey H. Fisher-Wellman and Rich
- Page 60 and 61:
40Kelsey H. Fisher-Wellman and Rich
- Page 62 and 63:
42Kelsey H. Fisher-Wellman and Rich
- Page 65 and 66:
In: Handbook of Vitamin C Research
- Page 67 and 68:
Human Specific Vitamin C Metabolism
- Page 69 and 70:
Human Specific Vitamin C Metabolism
- Page 71 and 72:
Human Specific Vitamin C Metabolism
- Page 73 and 74:
Human Specific Vitamin C Metabolism
- Page 75 and 76:
Human Specific Vitamin C Metabolism
- Page 77 and 78:
Human Specific Vitamin C Metabolism
- Page 79 and 80:
Human Specific Vitamin C Metabolism
- Page 81 and 82:
mgmgmgHuman Specific Vitamin C Meta
- Page 83 and 84:
Human Specific Vitamin C Metabolism
- Page 85 and 86:
Human Specific Vitamin C Metabolism
- Page 87 and 88:
Human Specific Vitamin C Metabolism
- Page 89 and 90:
Human Specific Vitamin C Metabolism
- Page 91 and 92:
Human Specific Vitamin C Metabolism
- Page 93 and 94:
Human Specific Vitamin C Metabolism
- Page 95 and 96:
Human Specific Vitamin C Metabolism
- Page 97 and 98:
Human Specific Vitamin C Metabolism
- Page 99 and 100:
Human Specific Vitamin C Metabolism
- Page 101 and 102:
Human Specific Vitamin C Metabolism
- Page 103 and 104:
Human Specific Vitamin C Metabolism
- Page 105:
Human Specific Vitamin C Metabolism
- Page 108 and 109:
88Ana I. Haza, Almudena García and
- Page 110 and 111:
90Figure 1.Ana I. Haza, Almudena Ga
- Page 112 and 113:
92Ana I. Haza, Almudena García and
- Page 114 and 115:
94Figure 3.Ana I. Haza, Almudena Ga
- Page 116 and 117:
96Ana I. Haza, Almudena García and
- Page 118 and 119:
98Ana I. Haza, Almudena García and
- Page 120 and 121:
100Ana I. Haza, Almudena García an
- Page 122 and 123:
102Ana I. Haza, Almudena García an
- Page 124 and 125:
104Ana I. Haza, Almudena García an
- Page 126 and 127:
106Ana I. Haza, Almudena García an
- Page 128 and 129:
108Ana I. Haza, Almudena García an
- Page 130 and 131:
110Ana I. Haza, Almudena García an
- Page 132 and 133:
112Ana I. Haza, Almudena García an
- Page 134 and 135:
114Ana I. Haza, Almudena García an
- Page 136 and 137:
116Ana I. Haza, Almudena García an
- Page 138 and 139:
118Ana I. Haza, Almudena García an
- Page 140 and 141:
120Ana I. Haza, Almudena García an
- Page 142 and 143:
122Ana I. Haza, Almudena García an
- Page 144 and 145:
124Ana I. Haza, Almudena García an
- Page 147 and 148:
In: Handbook of Vitamin C Research:
- Page 149 and 150:
Vitamin C: Dietary Requirements, Di
- Page 151 and 152:
Oxidative DamageVitamin C: Dietary
- Page 153 and 154:
Vitamin C: Dietary Requirements, Di
- Page 155 and 156:
Vitamin C: Dietary Requirements, Di
- Page 157 and 158:
Vitamin C: Dietary Requirements, Di
- Page 159 and 160:
Vitamin C: Dietary Requirements, Di
- Page 161 and 162:
Vitamin C: Dietary Requirements, Di
- Page 163 and 164:
Vitamin C: Dietary Requirements, Di
- Page 165 and 166:
Vitamin C: Dietary Requirements, Di
- Page 167 and 168:
Vitamin C: Dietary Requirements, Di
- Page 169 and 170:
Vitamin C: Dietary Requirements, Di
- Page 171 and 172:
Vitamin C: Dietary Requirements, Di
- Page 173 and 174:
In: Handbook of Vitamin C Research:
- Page 175 and 176:
Pro-Oxidant vs. Antioxidant Effects
- Page 177 and 178:
Pro-Oxidant vs. Antioxidant Effects
- Page 179 and 180:
Pro-Oxidant vs. Antioxidant Effects
- Page 181 and 182:
Pro-Oxidant vs. Antioxidant Effects
- Page 183 and 184:
Patient. B.H. (38), atopic eczema.V
- Page 185 and 186:
Pro-Oxidant vs. Antioxidant Effects
- Page 187 and 188:
Pro-Oxidant vs. Antioxidant Effects
- Page 189 and 190:
Pro-Oxidant vs. Antioxidant Effects
- Page 191 and 192:
Pro-Oxidant vs. Antioxidant Effects
- Page 193 and 194:
Pro-Oxidant vs. Antioxidant Effects
- Page 195 and 196:
Pro-Oxidant vs. Antioxidant Effects
- Page 197 and 198:
Pro-Oxidant vs. Antioxidant Effects
- Page 199 and 200:
Pro-Oxidant vs. Antioxidant Effects
- Page 201 and 202:
Pro-Oxidant vs. Antioxidant Effects
- Page 203:
Pro-Oxidant vs. Antioxidant Effects
- Page 206 and 207:
186Magdalena Stevanović and Dragan
- Page 208 and 209:
188Magdalena Stevanović and Dragan
- Page 210 and 211:
190Magdalena Stevanović and Dragan
- Page 212 and 213:
192Magdalena Stevanović and Dragan
- Page 214 and 215:
194Magdalena Stevanović and Dragan
- Page 216 and 217:
196Magdalena Stevanović and Dragan
- Page 218 and 219:
198Magdalena Stevanović and Dragan
- Page 220 and 221:
200Magdalena Stevanović and Dragan
- Page 222 and 223:
202Magdalena Stevanović and Dragan
- Page 224 and 225:
204Magdalena Stevanović and Dragan
- Page 226 and 227:
206Magdalena Stevanović and Dragan
- Page 228 and 229:
208Magdalena Stevanović and Dragan
- Page 230 and 231:
210Magdalena Stevanović and Dragan
- Page 233 and 234:
In: Handbook of Vitamin C Research
- Page 235 and 236:
Molecular Bases of the Cellular Han
- Page 237 and 238:
Molecular Bases of the Cellular Han
- Page 239 and 240:
Molecular Bases of the Cellular Han
- Page 241 and 242:
Molecular Bases of the Cellular Han
- Page 243 and 244:
Molecular Bases of the Cellular Han
- Page 245 and 246:
Molecular Bases of the Cellular Han
- Page 247 and 248:
Molecular Bases of the Cellular Han
- Page 249 and 250:
Molecular Bases of the Cellular Han
- Page 251 and 252:
Molecular Bases of the Cellular Han
- Page 253 and 254:
Molecular Bases of the Cellular Han
- Page 255 and 256:
Molecular Bases of the Cellular Han
- Page 257 and 258:
In: Handbook of Vitamin C Research
- Page 259 and 260:
Vitamin C: Daily Requirements, Diet
- Page 261 and 262:
Vitamin C: Daily Requirements, Diet
- Page 263 and 264:
Vitamin C: Daily Requirements, Diet
- Page 265 and 266:
Vitamin C: Daily Requirements, Diet
- Page 267 and 268:
Vitamin C: Daily Requirements, Diet
- Page 269 and 270:
Vitamin C: Daily Requirements, Diet
- Page 271 and 272:
Vitamin C: Daily Requirements, Diet
- Page 273 and 274:
Vitamin C: Daily Requirements, Diet
- Page 275 and 276:
Vitamin C: Daily Requirements, Diet
- Page 277 and 278:
Vitamin C: Daily Requirements, Diet
- Page 279:
Vitamin C: Daily Requirements, Diet
- Page 282 and 283:
262Alan M. Preston, Luis Vázquez Q
- Page 284 and 285:
264Alan M. Preston, Luis Vázquez Q
- Page 286 and 287:
266Alan M. Preston, Luis Vázquez Q
- Page 288 and 289:
Percent of Study Group Selecting Di
- Page 290 and 291:
270Alan M. Preston, Luis Vázquez Q
- Page 292 and 293:
272Alan M. Preston, Luis Vázquez Q
- Page 294 and 295:
274Alan M. Preston, Luis Vázquez Q
- Page 296 and 297:
276Alan M. Preston, Luis Vázquez Q
- Page 298 and 299:
278Alan M. Preston, Luis Vázquez Q
- Page 301 and 302:
In: Handbook of Vitamin C Research
- Page 303 and 304:
The Role of Vitamin C in Human Repr
- Page 305 and 306:
The Role of Vitamin C in Human Repr
- Page 307 and 308:
The Role of Vitamin C in Human Repr
- Page 309 and 310:
The Role of Vitamin C in Human Repr
- Page 311 and 312:
The Role of Vitamin C in Human Repr
- Page 313 and 314:
The Role of Vitamin C in Human Repr
- Page 315 and 316:
The Role of Vitamin C in Human Repr
- Page 317:
The Role of Vitamin C in Human Repr
- Page 320 and 321:
300Mustafa NazıroğluKeywords: Vit
- Page 322 and 323:
302Mustafa NazıroğluNO is synthes
- Page 324 and 325:
304Mustafa Nazıroğlu‗recycling
- Page 326 and 327:
306Mustafa Nazıroğluagents, such
- Page 328 and 329:
308Mustafa NazıroğluFuture Direct
- Page 330 and 331:
310Mustafa Nazıroğlu[21] Basu, TK
- Page 332 and 333:
312Mustafa Nazıroğlu[59] Cengiz M
- Page 334 and 335:
314Samar Al Sayegh Petkovšek and B
- Page 336 and 337:
316Samar Al Sayegh Petkovšek and B
- Page 338 and 339:
318Samar Al Sayegh Petkovšek and B
- Page 340 and 341:
(mgg -1 )320Samar Al Sayegh Petkov
- Page 342 and 343:
322Samar Al Sayegh Petkovšek and B
- Page 344 and 345:
324Samar Al Sayegh Petkovšek and B
- Page 346 and 347:
326Samar Al Sayegh Petkovšek and B
- Page 348 and 349:
328Samar Al Sayegh Petkovšek and B
- Page 350 and 351:
330Antonio J. López-Farré, José
- Page 352 and 353:
332Antonio J. López-Farré, José
- Page 354 and 355:
334Antonio J. López-Farré, José
- Page 356 and 357:
336Antonio J. López-Farré, José
- Page 358 and 359:
338Antonio J. López-Farré, José
- Page 360 and 361: 340Antonio J. López-Farré, José
- Page 363 and 364: In: Handbook of Vitamin C Research
- Page 365 and 366: Vitamin C in the Treatment of Endot
- Page 367 and 368: Vitamin C in the Treatment of Endot
- Page 369 and 370: Vitamin C in the Treatment of Endot
- Page 371 and 372: Vitamin C in the Treatment of Endot
- Page 373 and 374: Vitamin C in the Treatment of Endot
- Page 375 and 376: In: Handbook of Vitamin C Research
- Page 377 and 378: Vitamin C Intake by Japanese Patien
- Page 379 and 380: Vitamin C Intake by Japanese Patien
- Page 381 and 382: Vitamin C Intake by Japanese Patien
- Page 383 and 384: Vitamin C Intake by Japanese Patien
- Page 385 and 386: Vitamin C Intake by Japanese Patien
- Page 387 and 388: In: Handbook of Vitamin C Research
- Page 389 and 390: Reciprocal Effects of Ascorbate on
- Page 391 and 392: Reciprocal Effects of Ascorbate on
- Page 393 and 394: Reciprocal Effects of Ascorbate on
- Page 395: Reciprocal Effects of Ascorbate on
- Page 398 and 399: 378Akihito Ishigamicontrols (12,13)
- Page 400 and 401: 380Akihito IshigamiFigure 3. Vitami
- Page 402 and 403: 382Akihito IshigamiFuture of the SM
- Page 405 and 406: In: Handbook of Vitamin C Research
- Page 407 and 408: The Importance of Food Processing o
- Page 409: IndexAA , 249abdominal cramps, 243a
- Page 413 and 414: Index 393catalase, 6, 13, 169, 181,
- Page 415 and 416: Index 395cyclooxygenase-2, 337, 341
- Page 417 and 418: Index 397endometrium, 286, 294endon
- Page 419 and 420: Index 399GCS, 18gel, x, 87, 92, 121
- Page 421 and 422: Index 401hyperglycaemia, 223hypergl
- Page 423 and 424: Index 403kinetics, 71, 120, 124, 14
- Page 425 and 426: Index 405metastases, 182metastasis,
- Page 427 and 428: Index 407nitrate, 14, 88, 179, 234,
- Page 429 and 430: Index 409phosphodiesterase, 344, 35
- Page 431 and 432: Index 411recovery, vii, 1, 5, 7, 8,
- Page 433 and 434: Index 413steady state, 63, 76, 78st
- Page 435: Index 415UV, 156, 191, 201, 204, 22